Clinical Effects of Scaling and Root Planing in Treatment of Patients with Amlodipine Induced Gingival Overgrowth


calcium channel blockers
gingival overgrowth
scaling and root planing


Introduction: A multifactorial condition characterised by an increase in size is called gingival enlargement. Most common form is drug induced gingival enlargement. Different treatment options to manage gingival overgrowth are categorised as non-surgical approach and surgical approach. Non-surgical mechanical periodontal treatment is gold standard of periodontal therapy and first recommended approach to control of periodontal infections.

Objective: To determine clinical effect of scaling and root planing (SRP) in treatment of patient with amlodipine induced gingival overgrowth.

Methods: A pretest post-test study was conducted from January 2021 to December 2021 among 19 subjects recruited by convenience sampling who exhibited amlodipine induced gingival overgrowth of grade 1-2 (Miller’s and Damm index). The probing depth (PD) ≤7mm and clinical attachment level (CAL) ≤4 mm were evaluated on upper and lower anterior teeth on labial aspect, before and after SRP at one month, three months, and six months. Plaque index (PI), Gingival index (GI) were also evaluated before and after SRP at one month, three months, and six months.

Results: Statistically significant reduction was found in terms of GOS, PD, gain in CAL, PI, GI after treatment with SRP at one month, three months, and six months. However, results were not statistically significant in intragroup comparison post-treatment at one month, three months, and six months in terms of CAL, GI, and PI.

Conclusions: Scaling and root planing, has showed significant improvement in reduction of gingival overgrowth, probing depth, clinical attachment level, plaque index and gingival index as compared to pretreatment.



Newman MG, Takei H, Klokkevold PR, Carranza FA. Newman and Carranza's clinical periodontology.13th ed. Philadelphia (PA): Saunders, Elsevier; 2019. Chapter 19, Gingival enlargement; p. 256-67.e5.

Bhatia V, Mittal A, Parida AK, Talwar R, Kaul U. Amlodipine induced gingival hyperplasia: a rare entity. Int J Cardiol. 2007;122(3):e23-4.

Ellis JS, Seymour RA, Steele JG, Robertson P, Butler TJ, Thomason JM. Prevalence of gingival overgrowth induced by calcium channel blockers: A community-based study. J Periodontol. 1999;70(1):63-7.

Seymour RA. Effects of medications on the periodontal tissues in health and disease. Periodontol 2000. 2006;40(1):120-9.

Meraw SJ, Sheridan PJ. Medically induced gingival hyperplasia. Mayo Clin Proc. 1998;73(12):1196-9.

Greenstein G. Periodontal response to mechanical non-surgical therapy: A review. J Periodontol. 1992;63(2):118-30.

Mavrogiannis M, Ellis JS, Thomason JM, Seymour RA. The management of drug-induced gingival overgrowth. J Clin Periodontol. 2006;33(6):434-9.

Miller CS, Damm DD. Incidence of verapamil-induced gingival hyperplasia in a dental population. J Periodontol.1992;63(5):453-6.

Miranda J, Brunet L, Roset P, Farré M, Mendieta C. Reliability of two measurement indices for gingival enlargement. J Periodontal Res. 2012;47(6):776-82.

Livada R, Shiloah J. Calcium channel blocker-induced gingival enlargement. J Hum Hypertens. 2014;28(1):10-14.

Livada R, Shiloah J. Calcium channel blocker-induced gingival enlargement. J Hum Hypertens. 2014;28(1):10-4.

Angelopoulos AP, Goaz PW. Incidence of diphenylhydantoin gingival hyperplasia. Oral surg oral med oral pathol. 1972;34(6):898-906.

Hancock RH, Swan RH. Nifedipine-induced gingival overgrowth. Report of a case treated by controlling plaque. J Clin Periodontol.1992;19(1):12-4.

Kantarci A, Cebeci I, Tuncer O, Carin M, Firatli E. Clinical effects of periodontal therapy on the severity of cyclosporin A-induced gingival hyperplasia. J Periodontol. 1999;70(6):587-93.

Aimetti M, Romano F, Debernardi C. Effectiveness of periodontal therapy on the severity of cyclosporin A-induced gingival overgrowth. J Clin Periodontol. 2005;32(8):846-50

Montebugnoli L, Servidio D, Bernardi F. The rôle of time in reducing gingival overgrowth in heart-transplanted patients following cyclosporin therapy. J Clin Periodontol. 2000;27(8):611-4.

Aimetti M, Romano F, Marsico A, Navone R. Non-surgical periodontal treatment of cyclosporin A-induced gingival overgrowth: immunohistochemical results. Oral Dis. 2008;14(3):244-50.

Seymour RA, Smith DG. The effect of a plaque control programme on the incidence and severity of cyclosporin-induced gingival changes. J Clin Periodontol. 1991;18(2):107-10.

Hall EE. Prevention and treatment considerations in patients with drug-induced gingival enlargement. Curr Opin Periodontol. 1997;4:59-63.